The global infectious disease drugs market is booming, reaching $150 billion in 2025 and projected to grow at a CAGR of 4.30% until 2033. Driven by antimicrobial resistance and rising disease prevalence, key players like Sanofi and Gilead Sciences are leading innovation. Explore market trends, regional analysis, and key segments in this comprehensive report.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.